Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1990 Sep;86(3):952–961. doi: 10.1172/JCI114797

Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia.

J Zapf 1, C Schmid 1, H P Guler 1, M Waldvogel 1, C Hauri 1, E Futo 1, P Hossenlopp 1, M Binoux 1, E R Froesch 1
PMCID: PMC296815  PMID: 1697608

Abstract

Insulin-like growth factors (IGFs) in blood form two complexes with specific binding proteins (BPs): a large, growth hormone (GH)-dependent complex with restricted capillary permeability, and a smaller complex, inversely related to GH, with high turnover of its IGF pool and free capillary permeability. The distribution of BPs and of IGFs I and II between these complexes was studied in sera from healthy adults treated with IGF I or/and GH and from patients with extrapancreatic tumor hypoglycemia. Like GH, IGF I administration raises IGF I and two glycosylation variants of IGFBP-3 in the large complex, but unlike GH drastically reduces IGF II. During IGF I infusion, IGFBP-3 appears in the small complex whose IGFBP-2 and IGF I increase three- to fivefold and fivefold, respectively. GH treatment, associated with elevated insulin levels, suppresses IGFBP-2 and inhibits its increase owing to infused IGF I. The small complex of tumor sera contains increased amounts of IGFBP-2 and -3, and two- to threefold elevated IGF II. Conclusions: low GH and/or insulin during IGF I infusion and in extrapancreatic tumor hypoglycemia enhance expression of IGFBP-2 and favor partition of IGFBP-3 into the small complex. Free capillary passage and high turnover of its increased IGF I or II pools may contribute to compensate for suppressed insulin secretion during IGF I infusion or to development of tumor hypoglycemia.

Full text

PDF
952

Images in this article

953Image
on p.953
954Image
on p.954
954Image
on p.954
955Image
on p.955
956Image
on p.956
957Image
on p.957
957Image
on p.957
958Image
on p.958

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballard J., Baxter R., Binoux M., Clemmons D., Drop S., Hall K., Hintz R., Rechler M., Rutanen E., Schwander J. On the nomenclature of the IGF binding proteins. Acta Endocrinol (Copenh) 1989 Nov;121(5):751–752. doi: 10.1530/acta.0.1210751. [DOI] [PubMed] [Google Scholar]
  2. Baxter R. C., Martin J. L., Beniac V. A. High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum. J Biol Chem. 1989 Jul 15;264(20):11843–11848. [PubMed] [Google Scholar]
  3. Baxter R. C., Martin J. L. Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling. Proc Natl Acad Sci U S A. 1989 Sep;86(18):6898–6902. doi: 10.1073/pnas.86.18.6898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Binkert C., Landwehr J., Mary J. L., Schwander J., Heinrich G. Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2). EMBO J. 1989 Sep;8(9):2497–2502. doi: 10.1002/j.1460-2075.1989.tb08386.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Binoux M., Hossenlopp P. Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph. J Clin Endocrinol Metab. 1988 Sep;67(3):509–514. doi: 10.1210/jcem-67-3-509. [DOI] [PubMed] [Google Scholar]
  6. Brown A. L., Chiariotti L., Orlowski C. C., Mehlman T., Burgess W. H., Ackerman E. J., Bruni C. B., Rechler M. M. Nucleotide sequence and expression of a cDNA clone encoding a fetal rat binding protein for insulin-like growth factors. J Biol Chem. 1989 Mar 25;264(9):5148–5154. [PubMed] [Google Scholar]
  7. Böni-Schnetzler M., Binz K., Mary J. L., Schmid C., Schwander J., Froesch E. R. Regulation of hepatic expression of IGF I and fetal IGF binding protein mRNA in streptozotocin-diabetic rats. FEBS Lett. 1989 Jul 17;251(1-2):253–256. doi: 10.1016/0014-5793(89)81465-6. [DOI] [PubMed] [Google Scholar]
  8. Cohen K. L., Nissley S. P. The serum half-life of somatomedin activity: evidence for growth hormone dependence. Acta Endocrinol (Copenh) 1976 Oct;83(2):243–258. doi: 10.1530/acta.0.0830243. [DOI] [PubMed] [Google Scholar]
  9. Daughaday W. H., Kapadia M. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6778–6782. doi: 10.1073/pnas.86.17.6778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Daughaday W. H., Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev. 1989 Feb;10(1):68–91. doi: 10.1210/edrv-10-1-68. [DOI] [PubMed] [Google Scholar]
  11. De Mellow J. S., Baxter R. C. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun. 1988 Oct 14;156(1):199–204. doi: 10.1016/s0006-291x(88)80824-6. [DOI] [PubMed] [Google Scholar]
  12. Elgin R. G., Busby W. H., Jr, Clemmons D. R. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci U S A. 1987 May;84(10):3254–3258. doi: 10.1073/pnas.84.10.3254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fineberg S. E., Merimee T. J., Rabinowitz D., Edgar P. J. Insulin secretion in acromegaly. J Clin Endocrinol Metab. 1970 Mar;30(3):288–292. doi: 10.1210/jcem-30-3-288. [DOI] [PubMed] [Google Scholar]
  14. Furlanetto R. W. The somatomedin C binding protein: evidence for a heterologous subunit structure. J Clin Endocrinol Metab. 1980 Jul;51(1):12–19. doi: 10.1210/jcem-51-1-12. [DOI] [PubMed] [Google Scholar]
  15. Guler H. P., Schmid C., Zapf J., Froesch E. R. Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2868–2872. doi: 10.1073/pnas.86.8.2868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Guler H. P., Zapf J., Scheiwiller E., Froesch E. R. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4889–4893. doi: 10.1073/pnas.85.13.4889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Guler H. P., Zapf J., Schmid C., Froesch E. R. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh) 1989 Dec;121(6):753–758. doi: 10.1530/acta.0.1210753. [DOI] [PubMed] [Google Scholar]
  18. Hardouin S., Gourmelen M., Noguiez P., Seurin D., Roghani M., Le Bouc Y., Povoa G., Merimee T. J., Hossenlopp P., Binoux M. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance. J Clin Endocrinol Metab. 1989 Dec;69(6):1291–1301. doi: 10.1210/jcem-69-6-1291. [DOI] [PubMed] [Google Scholar]
  19. Hardouin S., Hossenlopp P., Segovia B., Seurin D., Portolan G., Lassarre C., Binoux M. Heterogeneity of insulin-like growth factor binding proteins and relationships between structure and affinity. 1. Circulating forms in man. Eur J Biochem. 1987 Dec 30;170(1-2):121–132. doi: 10.1111/j.1432-1033.1987.tb13676.x. [DOI] [PubMed] [Google Scholar]
  20. Hintz R. L., Liu F., Rosenfeld R. G., Kemp S. F. Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy. J Clin Endocrinol Metab. 1981 Jul;53(1):100–104. doi: 10.1210/jcem-53-1-100. [DOI] [PubMed] [Google Scholar]
  21. Hossenlopp P., Seurin D., Segovia-Quinson B., Binoux M. Identification of an insulin-like growth factor-binding protein in human cerebrospinal fluid with a selective affinity for IGF-II. FEBS Lett. 1986 Nov 24;208(2):439–444. doi: 10.1016/0014-5793(86)81065-1. [DOI] [PubMed] [Google Scholar]
  22. Hossenlopp P., Seurin D., Segovia-Quinson B., Hardouin S., Binoux M. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem. 1986 Apr;154(1):138–143. doi: 10.1016/0003-2697(86)90507-5. [DOI] [PubMed] [Google Scholar]
  23. Hossenlopp P., Seurin D., Segovia B., Portolan G., Binoux M. Heterogeneity of insulin-like growth factor binding proteins between structure and affinity. 2. Forms released by human and rat liver in culture. Eur J Biochem. 1987 Dec 30;170(1-2):133–142. doi: 10.1111/j.1432-1033.1987.tb13677.x. [DOI] [PubMed] [Google Scholar]
  24. Kahn C. R. The riddle of tumour hypoglycaemia revisited. Clin Endocrinol Metab. 1980 Jul;9(2):335–360. doi: 10.1016/s0300-595x(80)80037-5. [DOI] [PubMed] [Google Scholar]
  25. Knauer D. J., Smith G. L. Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7252–7256. doi: 10.1073/pnas.77.12.7252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Laron Z. Syndrome of familial dwarfism and high plasma immunoreactive growth hormone. Isr J Med Sci. 1974 Oct;10(10):1247–1253. [PubMed] [Google Scholar]
  27. Margot J. B., Binkert C., Mary J. L., Landwehr J., Heinrich G., Schwander J. A low molecular weight insulin-like growth factor binding protein from rat: cDNA cloning and tissue distribution of its messenger RNA. Mol Endocrinol. 1989 Jul;3(7):1053–1060. doi: 10.1210/mend-3-7-1053. [DOI] [PubMed] [Google Scholar]
  28. Martin J. L., Baxter R. C. Antibody against acid-stable insulin-like growth factor binding protein detects 150,000 mol wt growth hormone-dependent complex in human plasma. J Clin Endocrinol Metab. 1985 Oct;61(4):799–801. doi: 10.1210/jcem-61-4-799. [DOI] [PubMed] [Google Scholar]
  29. Meuli C., Zapf J., Froesch E. R. NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart. Diabetologia. 1978 Apr;14(4):255–259. doi: 10.1007/BF01219425. [DOI] [PubMed] [Google Scholar]
  30. Mottola C., MacDonald R. G., Brackett J. L., Mole J. E., Anderson J. K., Czech M. P. Purification and amino-terminal sequence of an insulin-like growth factor-binding protein secreted by rat liver BRL-3A cells. J Biol Chem. 1986 Aug 25;261(24):11180–11188. [PubMed] [Google Scholar]
  31. Ron D., Powers A. C., Pandian M. R., Godine J. E., Axelrod L. Increased insulin-like growth factor II production and consequent suppression of growth hormone secretion: a dual mechanism for tumor-induced hypoglycemia. J Clin Endocrinol Metab. 1989 Apr;68(4):701–706. doi: 10.1210/jcem-68-4-701. [DOI] [PubMed] [Google Scholar]
  32. Schmid C., Ernst M., Zapf J., Froesch E. R. Release of insulin-like growth factor carrier proteins by osteoblasts: stimulation by estradiol and growth hormone. Biochem Biophys Res Commun. 1989 Apr 28;160(2):788–794. doi: 10.1016/0006-291x(89)92502-3. [DOI] [PubMed] [Google Scholar]
  33. Schmid C., Zapf J., Froesch E. R. Production of carrier proteins for insulin-like growth factors (IGFs) by rat osteoblastic cells. Regulation by IGF I and cortisol. FEBS Lett. 1989 Feb 27;244(2):328–332. doi: 10.1016/0014-5793(89)80556-3. [DOI] [PubMed] [Google Scholar]
  34. Schwander J. C., Hauri C., Zapf J., Froesch E. R. Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology. 1983 Jul;113(1):297–305. doi: 10.1210/endo-113-1-297. [DOI] [PubMed] [Google Scholar]
  35. Widmer U., Zapf J., Froesch E. R. Is extrapancreatic tumor hypoglycemia associated with elevated levels of insulin-like growth factor II? J Clin Endocrinol Metab. 1982 Nov;55(5):833–839. doi: 10.1210/jcem-55-5-833. [DOI] [PubMed] [Google Scholar]
  36. Wilkins J. R., D'Ercole A. J. Affinity-labeled plasma somatomedin-C/insulinlike growth factor I binding proteins. Evidence of growth hormone dependence and subunit structure. J Clin Invest. 1985 Apr;75(4):1350–1358. doi: 10.1172/JCI111836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wood W. I., Cachianes G., Henzel W. J., Winslow G. A., Spencer S. A., Hellmiss R., Martin J. L., Baxter R. C. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Mol Endocrinol. 1988 Dec;2(12):1176–1185. doi: 10.1210/mend-2-12-1176. [DOI] [PubMed] [Google Scholar]
  38. Zapf J., Hauri C., Waldvogel M., Froesch E. R. Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. J Clin Invest. 1986 Jun;77(6):1768–1775. doi: 10.1172/JCI112500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Zapf J., Hauri C., Waldvogel M., Futo E., Häsler H., Binz K., Guler H. P., Schmid C., Froesch E. R. Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. Proc Natl Acad Sci U S A. 1989 May;86(10):3813–3817. doi: 10.1073/pnas.86.10.3813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Zapf J., Morell B., Walter H., Laron Z., Froesch E. R. Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders. Acta Endocrinol (Copenh) 1980 Dec;95(4):505–517. doi: 10.1530/acta.0.0950505. [DOI] [PubMed] [Google Scholar]
  41. Zapf J., Waldvogel M., Froesch E. R. Binding of nonsuppressible insulinlike activity to human serum. Evidence for a carrier protein. Arch Biochem Biophys. 1975 Jun;168(2):638–645. doi: 10.1016/0003-9861(75)90296-9. [DOI] [PubMed] [Google Scholar]
  42. Zapf J., Walter H., Froesch E. R. Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest. 1981 Nov;68(5):1321–1330. doi: 10.1172/JCI110379. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES